Category : Healthcare and Pharmaceuticals | Delivery Format: PDF | Status: Published | Pages : 190
CHAPTER 1. Industry Overview of Erythropoietin Drugs
1.1. Definition and Scope
1.1.1. Definition of Erythropoietin Drugs
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Erythropoietin Drugs Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Erythropoietin Drugs Market By Drug Class
1.2.3. Erythropoietin Drugs Market By Product
1.2.4. Erythropoietin Drugs Market By Application
1.2.5. Erythropoietin Drugs Market by Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Erythropoietin Drugs Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Erythropoietin Drugs Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2019
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2019
4.2. R&D Status and Application Source of Erythropoietin Drugs Major Manufacturers in 2019
CHAPTER 5. Erythropoietin Drugs Market By Drug Class
5.1. Introduction
5.2. Erythropoietin Drugs Revenue By Drug Class
5.2.1. Erythropoietin Drugs Revenue (US$ Mn) and Forecast, By Drug Class, 2016-2027
5.2.2. Biologics
5.2.2.1. Biologics Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3. Biosimilars
5.2.3.1. Biosimilars Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 6. Erythropoietin Drugs Market Revenue By Product
6.1. Introduction
6.2. Erythropoietin Drugs Revenue (US$ Mn) By Product
6.2.1. Erythropoietin Drugs Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
6.2.2. Epoetin-alfa
6.2.2.1. Epoetin-alfa Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3. Epoetin-beta
6.2.3.1. Epoetin-beta Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.4. Darbepoetin-alfa
6.2.4.1. Darbepoetin-alfa Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.5. Others
6.2.5.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 7. Erythropoietin Drugs Market By Application
7.1. Introduction
7.2. Erythropoietin Drugs Revenue (US$ Mn) By Application
7.2.1. Erythropoietin Drugs Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
7.2.2. Cancer
7.2.2.1. Cancer Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.2.3. Hematology
7.2.3.1. Hematology Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.2.4. Renal diseases
7.2.4.1. Renal diseases Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.2.5. Neurology
7.2.5.1. Neurology Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 8. North America Erythropoietin Drugs Market By Country
8.1. North America Erythropoietin Drugs Overview
8.2. U.S.
8.2.1. U.S. Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
8.2.2. U.S. Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.2.3. U.S. Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.3. Canada
8.3.1. Canada Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
8.3.2. Canada Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.3.3. Canada Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.4. North America PEST Analysis
CHAPTER 9. Europe Erythropoietin Drugs Market By Country
9.1. Europe Erythropoietin Drugs Market Overview
9.2. U.K.
9.2.1. U.K. Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
9.2.2. U.K. Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
9.2.3. U.K. Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
9.3. Germany
9.3.1. Germany Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
9.3.2. Germany Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
9.3.3. Germany Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
9.4. France
9.4.1. France Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
9.4.2. France Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
9.4.3. France Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
9.5. Spain
9.5.1. Spain Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
9.5.2. Spain Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
9.5.3. Spain Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
9.6. Rest of Europe
9.6.1. Rest of Europe Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
9.6.2. Rest of Europe Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
9.6.3. Rest of Europe Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
9.7. Europe PEST Analysis
CHAPTER 10. Asia Pacific Erythropoietin Drugs Market By Country
10.1. Asia Pacific Erythropoietin Drugs Market Overview
10.2. China
10.2.1. China Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
10.2.2. China Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
10.2.3. China Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.3. Japan
10.3.1. Japan Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
10.3.2. Japan Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
10.3.3. Japan Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.4. India
10.4.1. India Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
10.4.2. India Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
10.4.3. India Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.5. Australia
10.5.1. Australia Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
10.5.2. Australia Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
10.5.3. Australia Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.6. South Korea
10.6.1. South Korea Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
10.6.2. South Korea Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
10.6.3. South Korea Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
10.7.2. Rest of Asia-Pacific Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
10.7.3. Rest of Asia-Pacific Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.8. Asia Pacific PEST Analysis
CHAPTER 11. Latin America Erythropoietin Drugs Market By Country
11.1. Latin America Erythropoietin Drugs Market Overview
11.2. Brazil
11.2.1. Brazil Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
11.2.2. Brazil Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
11.2.3. Brazil Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
11.3. Mexico
11.3.1. Mexico Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
11.3.2. Mexico Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
11.3.3. Mexico Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
11.4. Rest of Latin America
11.4.1. Rest of Latin America Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
11.4.2. Rest of Latin America Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Product, 2016 – 2027
11.4.3. Rest of Latin America Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
11.5. Latin America PEST Analysis
CHAPTER 12. Middle East & Africa Erythropoietin Drugs Market By Country
12.1. Middle East & Africa Erythropoietin Drugs Market Overview
12.2. Saudi Arabia
12.2.1. Saudi Arabia Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
12.2.2. Saudi Arabia Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
12.2.3. Saudi Arabia Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
12.3. UAE
12.3.1. UAE Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
12.3.2. UAE Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
12.3.3. UAE Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
12.4.2. Rest of Middle East & Africa Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
12.4.3. Rest of Middle East & Africa Erythropoietin Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
12.5. Middle East & Africa PEST Analysis
CHAPTER 13. Player Analysis Of Erythropoietin Drugs
13.1. Erythropoietin Drugs Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global Erythropoietin Drugs Market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14. COMPANY PROFILE
14.1. Johnson & Johnson
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (US$ Mn), 2019
14.1.3.2. Johnson & Johnson 2019 Erythropoietin Drugs Business Regional Distribution
14.1.4. Product/ Service and Specification
14.1.5. Recent Developments & Business Strategy
14.1.6. Manufacturing Plant Footprint Analysis
14.2. Celltrion
14.3. Teva Pharmaceutical Industries Ltd.
14.4. Amgen, Inc.
14.5. F. Hoffmann-La Roche Ltd
14.6. LG Life Sciences Ltd.
14.7. Biocon Limited
14.8. Others
